Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Amanat

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Immunity|April 8, 2020
SARS-CoV-2 Vaccines: Status ReportFatima Amanat, Florian Krammer
Pathogens (Basel, Switzerland)|October 24, 2019
Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 HemagglutininShirin Strohmeier, Fatima Amanat, Florian Krammer
Emerging Microbes & Infections|March 15, 2019
Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse modelFatima Amanat, Philip Meade, Shirin Strohmeier, et al.
Frontiers in Immunology|August 15, 2022
Monoclonal antibodies targeting the influenza virus N6 neuraminidaseShirin Strohmeier, Fatima Amanat, Juan Manuel Carreño, et al.
Emerging Microbes & Infections|June 22, 2018
Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse modelDaniel Stadlbauer, Fatima Amanat, Shirin Strohmeier, et al.
Journal of Virology|December 6, 2019
Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus GlycoproteinFatima Amanat, James Duehr, Cheng Huang, et al.
NPJ Vaccines|July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in miceShirin Strohmeier, Fatima Amanat, John D Campbell, et al.
Msphere|May 4, 2018
Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World ArenavirusesFatima Amanat, James Duehr, Lisa Oestereich, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse modelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Mbio|March 3, 2021
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse ModelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Immunity|April 8, 2020
SARS-CoV-2 Vaccines: Status ReportFatima Amanat, Florian Krammer
Pathogens (Basel, Switzerland)|October 24, 2019
Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 HemagglutininShirin Strohmeier, Fatima Amanat, Florian Krammer
Emerging Microbes & Infections|March 15, 2019
Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse modelFatima Amanat, Philip Meade, Shirin Strohmeier, et al.
Frontiers in Immunology|August 15, 2022
Monoclonal antibodies targeting the influenza virus N6 neuraminidaseShirin Strohmeier, Fatima Amanat, Juan Manuel Carreño, et al.
Emerging Microbes & Infections|June 22, 2018
Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse modelDaniel Stadlbauer, Fatima Amanat, Shirin Strohmeier, et al.
Journal of Virology|December 6, 2019
Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus GlycoproteinFatima Amanat, James Duehr, Cheng Huang, et al.
NPJ Vaccines|July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in miceShirin Strohmeier, Fatima Amanat, John D Campbell, et al.
Msphere|May 4, 2018
Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World ArenavirusesFatima Amanat, James Duehr, Lisa Oestereich, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse modelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Mbio|March 3, 2021
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse ModelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Pageof 12